Grifols Sa (GRFS) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Grifols Sa  (NASDAQ: GRFS)


Grifols Sa's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Grifols Sa's ROA in the fourth quarter of 2025?
Grifols Sa achieved a return on average assets (ROA) of 2.54 % in its fourth quarter of 2025, which is below Grifols Sa's average return on assets, which stands at 2.57%.

ROA has improved compared to 1.06% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 215 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 1996.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -7.91 % -7.91 % -7.91 % -7.91 % -13.94 %
Y / Y Net Income Change 134.96 % - - - 17.79 %
Net Income (TTM) in million 560 238 238 238 238
Return On Assets (TTM) 2.54 % 1.06 % 1.04 % 1.01 % 0.99 %
GRFS's Total Ranking # 1996 # # # # 2544
Total Assets (TTM) in million 22,077 22,077 22,077 22,077 23,974
Seq. Total Assets Change 0 % 0 % 0 % -7.91 % 0 %
Seq. Net Income Change - - - - -

GRFS's 5 Years Annual ROA >> Back to GRFS Management Effectiveness >> Compare GRFS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 78
Sector # 216
Overall # 1984

Return On Assets Statistics
High Average Low
4.76 %
2.57 %
0.84 %
(Dec 31 2018)   (Dec 31 2023)





Financial Statements
Grifols Sa's Assets $ 22,077 million GRFS's Balance sheet
Grifols Sa's Income $ 560 million Quarterly GRFS's Income Statement
GRFS's Income by Division See GRFS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -7.91 % -0.17 % -0.43 % 11.96 % 25.92 %
Total Assets in million 22,077 23,974 24,014 24,118 21,542
Y / Y Net Income Change 134.96 % 17.79 % -33.37 % 2.19 % -62.58 %
Net Income in million 560 238 202 304 297
Annual Return On Assets 2.54 % 0.99 % 0.84 % 1.26 % 1.38 %

GRFS's 5 Years Annual ROA >> Back to GRFS Management Effectiveness >> Compare GRFS ROA to its Competitors



Comment on GRFS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 2.54 % compared to prior year, due to annual net income growth of 134.96 % to $560.00 million, and due to decline of value in Grifols Sa's assets by -7.91 % to $22,077.44 million, compared to $22,077.44 a year before.


More Return On Assets Ratios
GRFS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GRFS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GRFS's Competitors
Subscribers only: Roa for Grifols Sa's Suppliers
Subscribers only: Return On Assets for GRFS's Customers

You may also want to know
GRFS's Roi GRFS's Inventory Turnover Ratio GRFS's Growth Rates GRFS's Dividend Comparisons
GRFS's Profitability Ratios GRFS's Asset Turnover Ratio GRFS's Dividend Growth
GRFS's Roe GRFS's Valuation Ratios GRFS's Financial Strength Ratios GRFS's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Stryker Corp  6.93 %
Steris Plc  6.92 %
Boston Scientific Corporation  6.88 %
Phibro Animal Health Corporation  6.79 %
Qiagen N v   6.76 %
Royalty Pharma Plc  6.76 %
Addus Homecare Corp  6.76 %
Ensign Group Inc  6.76 %
Brainsway Ltd   6.69 %
Align Technology inc   6.62 %
Ironwood Pharmaceuticals inc   6.57 %
Infusystem Holdings Inc  6.55 %
Quest Diagnostics Inc  6.52 %
Davita Inc   6.20 %
Sanofi  6.19 %
Concentra Group Holdings Parent Inc   6.13 %
Hologic Inc  6.12 %
Option Care Health Inc   6.09 %
Kewaunee Scientific Corporation  6.07 %
Ge Healthcare Technologies Inc   6.06 %
Amphastar Pharmaceuticals Inc   6.00 %
Smith and Nephew Plc  5.98 %
Talkspace Inc   5.87 %
Cadre Holdings inc   5.86 %
Ani Pharmaceuticals Inc  5.71 %
Stevanato Group S p a   5.50 %
Escalon Medical Corp   5.48 %
Kamada Ltd   5.33 %
Medtronic Plc  5.07 %
Community Health Systems Inc   5.01 %

Date modified: 2026-06-22T16:58:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.